Health Condition 1: F90- Attention-deficit hyperactivity disorders
Conditions
Interventions
Intervention1: Melatonin: Melatonin will be supplemented in doses of 3mg or 5mg according to body weight using oral tablets and response will be studied over a total duration of 6 weeks
Control Interv
Sponsors
King george medical university
Eligibility
Inclusion criteria
Inclusion criteria: Children diagnosed with ADHD willing to participate after taking a written informed consent from the primary caregiver with the assent of the patient Children between ages 6 and 16 years Experiencing sleep disturbances assessed using a cutoff score of 41 on the CSHQ scale Treatment for ADHD continued as usual on stable dose of medication for past 4 weeks
Exclusion criteria
Exclusion criteria: Children diagnosed with intellectual disability Children diagnosed with autism spectrum disorder Children diagnosed with epilepsy or any other neurological condition
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Melatonin supplementation will improve sleep and cognition among children aged 6 to 16 years diagnosed with Attention-Deficit/Hyperactivity disorder experiencing Sleep disturbancesTimepoint: Baseline 2 weeks 4 weeks 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Not applicableTimepoint: Not applicable | — |
Countries
India
Contacts
Public ContactDr Ritwick Tripathi
King George medical university
Outcome results
None listed